December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eton Pharmaceuticals, Inc. - Common Stock (NQ:ETON)

16.80 -0.44 (-2.55%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eton Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Why is Yield10 Bioscience (YTEN) Stock Down 46% Today? ↗
Yield10 Bioscience (YTEN) stock is falling hard on Friday with heavy trading after a public share offering went into effect. 
Via InvestorPlace
News headline image
Why Semler Scientific Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket ↗
Gainers Amyris, Inc. (NASDAQ: AMRS) shares surged 45.4% to $0.0958 in pre-market trading. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy. 
Via Benzinga
Topics Bankruptcy
News headline image
Why Is Eton Pharmaceuticals (ETON) Stock Up 30% Today? ↗
Eton Pharmaceuticals (ETON) stock is soaring following the release of its earnings report for the second quarter of 2023! 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
News headline image
Recap: Eton Pharmaceuticals Q1 Earnings ↗
 
Via Benzinga
News headline image
Looking Into Eton Pharmaceuticals's Return On Capital Employed ↗
 
Via Benzinga
News headline image
A Preview Of Eton Pharmaceuticals's Earnings ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Wells Fargo To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Monday ↗
Jefferies boosted the price target for ACM Research, Inc. (NASDAQ: ACMR) from $9 to $23.4. Jefferies analyst Nick Cheng upgraded the stock from Underperform to Buy. ACM Research shares fell 2.2% to... 
Via Benzinga
Looking Into Eton Pharmaceuticals's Return On Capital Employed ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Stocks Mixed Following Hawkish Fed Comments ↗
Stocks are mixed, as investors unpack comments from U.S. Federal Reserve Chairman Jerome Powell before the European Central Bank (ECB). 
Via Talk Markets
News headline image
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Reports First Quarter 2023 Financial Results
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution)
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals, GeoVax Labs And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗
The Nasdaq Composite dropped by around 200 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
News headline image
Looking Into Eton Pharmaceuticals's Return On Capital Employed ↗
According to data from Benzinga Pro, during Q2, Eton Pharmaceuticals's (NASDAQ:ETON) reported sales totaled $7.36 million. Despite a 70.77% increase in earnings, the company posted a loss of $1.56... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.